EUVIMEDEUVIMED entdecken
Crossref

Considerations for infection risks identified in target safety review

Yuichiro Amano, Yoshitaka Inui, Satoko Yoshioka, Jodi Goodwin

The Journal of Toxicological Sciences · 2026 · 51 (4) · 251-258

DOI: 10.2131/jts.51.251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2026. Verfasst von Yuichiro Amano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nonclinical Safety and Pharmacology, Research, Takeda Pharmaceutical Company Limited. Hauptthemen laut MEDLINE: Biological Products, Drug-Related Side Effects and Adverse Reactions, Infections. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsDrug-Related Side Effects and Adverse ReactionsInfectionsAnimalsHumansAntibodies, MonoclonalRisk Assessment

Stichwörter der Autor:innen

ImmunotoxicityInfection RisksTarget Safety Review

Substanzen

Antibodies, MonoclonalBiological Products

Autor:innen und Institutionen

  • Nonclinical Safety and Pharmacology, Research, Takeda Pharmaceutical Company Limited.

Zitieren

APA

Amano, Y., Inui, Y., Yoshioka, S., & Goodwin, J. (2026). Considerations for infection risks identified in target safety review. The Journal of Toxicological Sciences, 51(4), 251-258. https://doi.org/10.2131/jts.51.251

Vancouver

Amano Y, Inui Y, Yoshioka S, Goodwin J. Considerations for infection risks identified in target safety review. The Journal of Toxicological Sciences. 2026;51(4):251-258. doi:10.2131/jts.51.251

BibTeX
@article{Amano2026,
  author = {Amano, Yuichiro and Inui, Yoshitaka and Yoshioka, Satoko and Goodwin, Jodi},
  title = {Considerations for infection risks identified in target safety review},
  journal = {The Journal of Toxicological Sciences},
  year = {2026},
  volume = {51},
  number = {4},
  pages = {251--258},
  doi = {10.2131/jts.51.251}
}
Kostenlos starten →